145 related articles for article (PubMed ID: 36220845)
41. Retinal sensitivity after photodynamic therapy with half-dose verteporfin for chronic central serous chorioretinopathy: short-term results.
Fujita K; Yuzawa M; Mori R
Retina; 2011 Apr; 31(4):772-8. PubMed ID: 20890236
[TBL] [Abstract][Full Text] [Related]
42. Long-term outcomes of half-fluence photodynamic therapy and eplerenone in chronic central serous chorioretinopathy: A comparative study.
Manayath G; Verghese S; Ranjan R; Agrawal H; Khanna A; Narendran V; Chhablani J
Eur J Ophthalmol; 2021 Nov; 31(6):3110-3116. PubMed ID: 33508971
[TBL] [Abstract][Full Text] [Related]
43. Comparison of the fluorescein angiography-guided and indocyanine green angiography-guided photodynamic therapy in the treatment of non-resolving central serous chorioretinopathy.
Ebrahimiadib N; Mirzaei A; Esfandiarifard S; Tuli S; Najibzadeh E; Imani Fooladi M; Fadakar K
Sci Rep; 2023 Jan; 13(1):1682. PubMed ID: 36717729
[TBL] [Abstract][Full Text] [Related]
44. Long-term chorioretinal changes after photodynamic therapy for chronic central serous chorioretinopathy.
Vasconcelos H; Marques I; Santos AR; Melo P; Pires I; Figueira J; de Abreu JF; Cachulo ML; Silva R
Graefes Arch Clin Exp Ophthalmol; 2013 Jul; 251(7):1697-705. PubMed ID: 23389551
[TBL] [Abstract][Full Text] [Related]
45. Microstructural changes after half-dose photodynamic therapy in patients with chronic central serous chorioretinopathy.
Esen E; Sizmaz S; Demircan N
Photodiagnosis Photodyn Ther; 2021 Sep; 35():102347. PubMed ID: 34033938
[TBL] [Abstract][Full Text] [Related]
46. COMPARISON OF SHORT-TERM EFFICACY BETWEEN ORAL SPIRONOLACTONE TREATMENT AND PHOTODYNAMIC THERAPY FOR THE TREATMENT OF NONRESOLVING CENTRAL SEROUS CHORIORETINOPATHY.
Lee JH; Lee SC; Kim H; Lee CS
Retina; 2019 Jan; 39(1):127-133. PubMed ID: 29095358
[TBL] [Abstract][Full Text] [Related]
47. Early choriocapillaris changes after half-fluence photodynamic therapy in chronic central serous chorioretinopathy evaluated by optical coherence tomography angiography: Preliminary results.
Demircan A; Yesilkaya C; Alkin Z
Photodiagnosis Photodyn Ther; 2018 Mar; 21():375-378. PubMed ID: 29409857
[TBL] [Abstract][Full Text] [Related]
48. Yellow (577 nm) micropulse laser versus half-dose verteporfin photodynamic therapy in eyes with chronic central serous chorioretinopathy: results of the Pan-American Collaborative Retina Study (PACORES) Group.
Roca JA; Wu L; Fromow-Guerra J; Rodríguez FJ; Berrocal MH; Rojas S; Lima LH; Gallego-Pinazo R; Chhablani J; Arevalo JF; Lozano-Rechy D; Serrano M
Br J Ophthalmol; 2018 Dec; 102(12):1696-1700. PubMed ID: 29439089
[TBL] [Abstract][Full Text] [Related]
49. INSTRUMENTAL DIFFERENCE IN ASSESSING CHOROIDAL HYPERPERMEABILITY AND PHOTODYNAMIC THERAPY IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHY.
Lee SM; Kwon HJ; Park SW; Lee JE; Byon IS
Retina; 2019 Jul; 39(7):1361-1369. PubMed ID: 29554076
[TBL] [Abstract][Full Text] [Related]
50. Efficacy of half-fluence photodynamic therapy depending on the degree of choroidal hyperpermeability in chronic central serous chorioretinopathy.
Lim SH; Chang W; Sagong M
Eye (Lond); 2013 Mar; 27(3):353-62. PubMed ID: 23449515
[TBL] [Abstract][Full Text] [Related]
51. Long-term results of focal laser photocoagulation and photodynamic therapy for the treatment of central serous chorioretinopathy.
Shin YI; Kim KM; Lee MW; Kim JY; Jo YJ
Jpn J Ophthalmol; 2020 Jan; 64(1):28-36. PubMed ID: 31863228
[TBL] [Abstract][Full Text] [Related]
52. Half-dose photodynamic therapy followed by diode micropulse laser therapy as treatment for chronic central serous chorioretinopathy: evaluation of a prospective treatment protocol.
Breukink MB; Mohr JK; Ossewaarde-van Norel A; den Hollander AI; Keunen JE; Hoyng CB; Boon CJ
Acta Ophthalmol; 2016 Mar; 94(2):187-97. PubMed ID: 26670630
[TBL] [Abstract][Full Text] [Related]
53. Multimodal Imaging and Choroidal Volumetric Changes After Half-fluence PDT in Central Serous Chorioretinopathy.
Munk MR; Shah R; Pappas F; Baddar D; Wong B; Jampol LM; Fawzi AA
Curr Eye Res; 2016; 41(1):97-106. PubMed ID: 25612245
[TBL] [Abstract][Full Text] [Related]
54. Analysis of choriocapillaris perfusion and choroidal layer changes in patients with chronic central serous chorioretinopathy randomised to micropulse laser or photodynamic therapy.
Ho M; Lai FHP; Ng DSC; Iu LPL; Chen LJ; Mak ACY; Yip Y; Cheung C; Young AL; Brelen M
Br J Ophthalmol; 2021 Apr; 105(4):555-560. PubMed ID: 32532761
[TBL] [Abstract][Full Text] [Related]
55. Factors for recurrence in acute central serous chorioretinopathy patients underwent one-third dose verteporfin photodynamic therapy.
Zhang X; Zhuang X; Dong J; Fu B; Xu L
Photodiagnosis Photodyn Ther; 2022 Sep; 39():102984. PubMed ID: 35753673
[TBL] [Abstract][Full Text] [Related]
56. Isolated pigment epithelium detachment: evidence for relation to central serous chorioretinopathy and effect of photodynamic therapy.
Arif F; Pryds A; Larsen M
Acta Ophthalmol; 2018 Dec; 96(8):821-827. PubMed ID: 30246489
[TBL] [Abstract][Full Text] [Related]
57. Long-Term Effects of Half-Time Photodynamic Therapy on Retinal Sensitivity in Eyes with Chronic Central Serous Chorioretinopathy.
Iwase T; Yokouchi H; Kitahashi M; Kubota-Taniai M; Baba T; Yamamoto S
Biomed Res Int; 2020; 2020():3190136. PubMed ID: 32908883
[TBL] [Abstract][Full Text] [Related]
58. Foveal and Extrafoveal Effects of Half-Dose Photodynamic Therapy in Chronic Central Serous Chorioretinopathy: A Cohort Study.
Pinto C; Sousa K; Oliveira E; Mendonça L; Gentil R; Queirós L; Falcão M
Semin Ophthalmol; 2022 Feb; 37(2):153-157. PubMed ID: 34027797
[TBL] [Abstract][Full Text] [Related]
59. Morphological and Functional Changes Immediately After Half-Time Photodynamic Therapy in Patients With Central Serous Chorioretinopathy.
Muslubas IS; Ersoz MG; Hocaoglu M; Arf S; Karacorlu M
Ophthalmic Surg Lasers Imaging Retina; 2018 Dec; 49(12):932-940. PubMed ID: 30566700
[TBL] [Abstract][Full Text] [Related]
60. One-year choroidal thickness results after photodynamic therapy for central serous chorioretinopathy.
Maruko I; Iida T; Sugano Y; Furuta M; Sekiryu T
Retina; 2011 Oct; 31(9):1921-7. PubMed ID: 21878850
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
